These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9168938

  • 1. Transcriptional activation of human LIM-HOX gene, hLH-2, in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK, Minden MD.
    Biochem Biophys Res Commun; 1997 Apr 28; 233(3):806-12. PubMed ID: 9168938
    [Abstract] [Full Text] [Related]

  • 2. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK, Minden MD.
    Biochem Biophys Res Commun; 1997 May 29; 234(3):742-7. PubMed ID: 9175786
    [Abstract] [Full Text] [Related]

  • 3. Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1.
    Wu HK, Heng HH, Siderovski DP, Dong WF, Okuno Y, Shi XM, Tsui LC, Minden MD.
    Oncogene; 1996 Mar 21; 12(6):1205-12. PubMed ID: 8649822
    [Abstract] [Full Text] [Related]

  • 4. Detailed mapping of methylcytosine positions at the CpG island surrounding the Pa promoter at the bcr-abl locus in CML patients and in two cell lines, K562 and BV173.
    Fajkusová L, Fajkus J, Polácková K, Fulnecek J, Dvoráková D, Krahulcová E.
    Blood Cells Mol Dis; 2000 Jun 21; 26(3):193-204. PubMed ID: 10950939
    [Abstract] [Full Text] [Related]

  • 5. Detection of bcr-abl fusion mRNA in chronic myelogenous leukemia by reverse transcription polymerase chain reaction using nested primers.
    Furukawa Y, Ju SL, Cho HL, Tatsumi N.
    Osaka City Med J; 1993 Jun 21; 39(1):35-45. PubMed ID: 7694218
    [Abstract] [Full Text] [Related]

  • 6. A structurally abnormal breakpoint cluster region gene in a transcription factor, hLH-2-negative human leukemia cell line.
    Wu HK.
    Cancer Lett; 1995 Jun 08; 92(2):215-22. PubMed ID: 7600533
    [Abstract] [Full Text] [Related]

  • 7. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
    Lawrence HJ, Sauvageau G, Ahmadi N, Lopez AR, LeBeau MM, Link M, Humphries K, Largman C.
    Exp Hematol; 1995 Oct 08; 23(11):1160-6. PubMed ID: 7556525
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of the LH2 gene in chronic myeloid leukaemia cells.
    Al-Jehani F, Hochhaus A, Spencer A, Goldman JM, Melo JV.
    Leukemia; 1996 Jul 08; 10(7):1122-6. PubMed ID: 8683990
    [Abstract] [Full Text] [Related]

  • 11. ABL1 promoter methylation can exist independently of BCR-ABL transcription in chronic myeloid leukemia hematopoietic progenitors.
    Sun B, Jiang G, Zaydan MA, La Russa VF, Safah H, Ehrlich M.
    Cancer Res; 2001 Sep 15; 61(18):6931-7. PubMed ID: 11559572
    [Abstract] [Full Text] [Related]

  • 12. The molecular biology of chronic myeloid leukaemia.
    Melo JV.
    Leukemia; 1996 May 15; 10(5):751-6. PubMed ID: 8656667
    [Abstract] [Full Text] [Related]

  • 13. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K, Aoki M, Kawamata S, Shinozuka Y, Era T, Taniwaki M, Hattori M, Minato N.
    Cancer Res; 2006 Oct 15; 66(20):9967-76. PubMed ID: 17047059
    [Abstract] [Full Text] [Related]

  • 14. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 15. Mutator phenotype of BCR--ABL transfected Ba/F3 cell lines and its association with enhanced expression of DNA polymerase beta.
    Canitrot Y, Lautier D, Laurent G, Fréchet M, Ahmed A, Turhan AG, Salles B, Cazaux C, Hoffmann JS.
    Oncogene; 1999 Apr 29; 18(17):2676-80. PubMed ID: 10348341
    [Abstract] [Full Text] [Related]

  • 16. [Study on mismatch repair genes of chronic myeloid leukemia].
    Luo J, Peng ZG, Chen Y, Lai YR, Lu YY, Song SJ.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb 29; 27(2):103-6. PubMed ID: 16732964
    [Abstract] [Full Text] [Related]

  • 17. [Molecular analysis of transformation into blast crisis in chronic myelogenous leukemia].
    Okabe M.
    Hokkaido Igaku Zasshi; 1993 Mar 29; 68(2):237-50. PubMed ID: 8509066
    [Abstract] [Full Text] [Related]

  • 18. Constitutive and specific activation of STAT3 by BCR-ABL in embryonic stem cells.
    Coppo P, Dusanter-Fourt I, Millot G, Nogueira MM, Dugray A, Bonnet ML, Mitjavila-Garcia MT, Le Pesteur D, Guilhot F, Vainchenker W, Sainteny F, Turhan AG.
    Oncogene; 2003 Jun 26; 22(26):4102-10. PubMed ID: 12821944
    [Abstract] [Full Text] [Related]

  • 19. Progressive de novo DNA methylation at the bcr-abl locus in the course of chronic myelogenous leukemia.
    Zion M, Ben-Yehuda D, Avraham A, Cohen O, Wetzler M, Melloul D, Ben-Neriah Y.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10722-6. PubMed ID: 7938018
    [Abstract] [Full Text] [Related]

  • 20. Long-template DNA polymerase chain reaction for the detection of the bcr/abl translocation in patients with chronic myelogenous leukemia.
    Waller CF, Dennebaum G, Feldmann C, Lange W.
    Clin Cancer Res; 1999 Dec 25; 5(12):4146-51. PubMed ID: 10632353
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.